The role of telomeres in etoposide induced tumor cell death

Cell Cycle

Volumn 3, Issue 9, 2004, Pages 1169-1176

  Jeyapalan, Jessie ^a,b   Leake, Alan ^a   Ahmed, Shaheda ^a   Saretzki, Gabriele ^a   Tilby, Michael ^b   Von Zglinicki, Thomas ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; DNA damage; Etoposide; Growth arrest; Telomerase; Telomeres; Tumor

Indexed keywords

DNA; ETOPOSIDE; TELOMERASE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; SIGNAL TRANSDUCTION; TELOMERE; TUMOR CELL;

EID: 13944281338     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gellert M, Mitzuuchi K, O'Dea MH, Nash HA. DNA gyrase: An enzyme that integrates supethelical turns into DNA. Proc Nat Acad Sci USA 1976; 73:3872-6.
2. Wang JC. DNA topoisomerases. Ann Rev Biochem 1996; 65:635-92.
3. Kaufmann SH. Cell death induced by topoisomerase targeted drugs: More questions than answers. Biochim Biophys Acta 1998; 1400:195-211.
4. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27:339-44.
5. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, et al. Mammalian telomeres end in a large duplex loop. Cell 1999; 97:503-14.
6. Stewart SA, Ben-Porath I, Carey VJ, O'Connor BF, Hahn WC, Weinberg RA. Erosion of the telomeric single stranded overhang at replicative senescence. Nat Genet 2003; 33:492-6.
7. Saretzki G, Sitte N, Merkel U, Wurm RE, von Zglinicki T. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. Oncogene 1999; 18:5148-58.
8. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 2000; 908:99-110.
9. Greider CW, Blackburn EH. The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987; 51:887-98.
10. Greider CW, Blackburn EH. A telomeric sequence in the RNA of tetrahymena telomerase required for telomere repeat synthesis. Nature 1989; 337:331-7.
11. Herbert BS, Pitts AE, Baker SI, Hamiliton SE, Wright WE, Shay JW, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Nat Acad Sci USA 1999; 96:14276-81.
12. Saretzki G, Ludwig A, von Zglinicki T, Runebaum IB. Ribozyme mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther 2001; 8:27-34.
13. Yoon HJ, Choi IY, Kang MR, Kim SS, Muller MT, Spitzner JR, et al. DNA topoisomerases II cleavage of telomeres in vitro and in vivo. Biochim Biophys Acta 1998; 1395:110-20.
14. Moriarty TJ, Dupuis S, Autexier C. Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA damaging drug etoposide. Leukemia 2002; 16:1112-0.
15. Klappet W, Qian W, Schukte C, Parwaresch R. DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia 2003; 17:2007-15.
16. Sato N, Mizumoto K, Nishio S, Maehara N, Urashima T, Ogawa T, et al. Up-regulation of telomerase activity in human pancreatic cancel cells after exposure to etoposide. Br J Cancer 2000; 82:1819-26.
17. Li D, Zhang Y, Cao W, Sun L, Xu H, Lu W. Regulative function of telomerase and extracellular regulated protein kinases to leukemic cell apoptosis. J Huazhong Univ Sci Technolog Med Sci 2002; 22:292-301.
18. Akiyama M, Horiguchi-Yamada J, Saito S, Hoshi Y, Yamada O, Mizoguchi H, et al. Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro. Eur J Cancer 1999; 35:309-15.
19. Ku WC, Cheng AJ, Wang TC. Inhibition of telomerase activity by PKC inhibitors in human nasoparyngeal cancer cells in culture. Biochem Biophys Res Comm 1997; 241:730-6.
20. Ludwig A, Saretzki G, Holm PS, Tiemann F, Lorenz M, Emrich T, et al. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoiomerase. Cancer Res 2001; 61:3053-61.
21. Misawa M, Tauchi T, Sashida G, Nakajima A, Abe K, Ohyashiki JH, et al. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol 2002; 21:1087-92.
22. Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. TERT suppresses apoptosis at a pre-mitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein binding activity. FASEB J 2003; 17:767-9.
23. Chen Z, Koeneman KS, Corey DR. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells. Cancer Res 2003; 63:5917-25.
24. Folini M, De Marco C, Orlandi ML, Daidone MG, Zaffaroni N. Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents. Eur J Cancer 2000; 36:2137-45.
25. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res 1989; 49:219-25.
26. Sgonc R, Gruber J. Apoptosis detection: An overview. Exp Gerontol 1998; 33:525-33.
27. Brabeck C, Pfeiffer R, Leake A, Beneke S, Meyer R, Burkle A. L-selegiline potentiates the cellular poly(ADP-ribosyl)ation response to ionizing radiation. J Pharmacol Exp Ther 2003; 306:973-9.
28. von Zglinicki T, Pilger R, Sitte N. Accumulation of single stand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med 2000; 28:64-74.
29. Keys B, Serra V, Saretzki G, von Zglinicki T. Telomere shortening in human fibroblasts is not dependent on the size of the telomeric-3′- overhang. Aging Cell 2004; 3:103-9.
30. D'adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T, et al. A DNA damage checkpoint response in telomereinititated senescence. Nature 2003; 426:194-8.
31. de Lange T. Telomere capping-one strand fits all. Science 2001; 292:1075-6.
32. Blackburn EH. Switching and signalling at the telomere. Cell 2001; 106:661-73.
33. von Zglinicki T. Telomeres and replicative senescence: Is it only length that counts? Cancer Lett 2001; 168:111-6.
34. von Zglinicki T, Burkle A, Kirkwood BL. Stress, DNA damage and ageing- an integrative approach. Exp Gerontol 2001; 36:1046-62.
35. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: Relation to aging. Proc Nat Acad Sci USA 1995; 92:258-62.
36. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblast: A model for senescence? Exp Cell Res 1995; 220:186-93.
37. Lee K, Rudolph L, Ju Y, Greenberg RA, Cannizzaro L, Chin L, et al. Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Nat Acad Sci USA 2001; 98:3381-6.
38. Spiropoulou T, Ferekidou L, Angelopoulou K, Stathopoulou A, Talieri M, Lianidou ES. Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase beta plus transcript in MCF-7 cells. Clin Biochem 2004; 37:299-304.
39. Sharma G, Gupta J, Wang H, Scherthan H, Dhar S, Gandhi V, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003; 22:131-46.